#4714 on the rich list of 14,452 insiders
Nikhil Lalwani
PRESIDENT & CEO at ANI Pharmaceuticals. Based in Princeton, New Jersey.
$22.7M
in disclosed stock, −$768K (−3.27%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4714th of 14,452
- Companies held
- 1
- Largest holding
- ANIP, 100.0% of total
- Latest SEC filing
- Nov 18, 2026
What the $22.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ANI Pharmaceuticals ANIP Common Stock | Directly | 328,289 | $69.13 | $22.7M | 100.0% | Form 4, Nov 18, 2026 |
Share counts are the amounts Nikhil Lalwani reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4711 | Thomas Nichols Thompson Director, Truist Financial. Charlotte, NC | $22.7M |
| 4712 | Anthony Capuano President & CEO, Marriott International. Bethesda, MD | $22.7M |
| 4713 | Marcus G. Smith Director, Sonic Automotive. Concord, NC | $22.7M |
| 4714 | Nikhil Lalwani PRESIDENT & CEO, ANI Pharmaceuticals. Princeton, NJ | $22.7M |
| 4715 | Adaire Fox-Martin CEO and President, Equinix. Redwood City, CA | $22.7M |
| 4716 | Amanda Whalen Chief Financial Officer, Klaviyo. Boston, MA | $22.7M |
| 4717 | Marsha C. Williams Director, Modexus Solutions. Tampa, FL | $22.7M |
Other ANI Pharmaceuticals insiders
All ANIP insiders- Muthusamy Shanmugam$37.2MHEAD OF R&D, COO-NOVITIUM OPS. #3176 overall
- Chad Gassert$16.1MSVP - CORP. DEV. & STRATEGY. #6071 overall
- Stephen P. Carey$11.5MSVP & CFO. #7910 overall
- James G. Marken$8.1MSVP OPS & PROD DEV. #10253 overall
- Christopher Mutz$6.3MHEAD OF RARE DISEASE. #12326 overall
- Ori Gutwerg$5.2MSVP, GENERICS. #14038 overall
Questions
How much stock does Nikhil Lalwani own?
Nikhil Lalwani holds $22,694,619 in listed stock based on SEC filings and current prices, mostly ANI Pharmaceuticals (ANIP). That ranks 4714th on the Stock Rich List.
Is this Nikhil Lalwani's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Nikhil Lalwani last buy or sell stock?
The most recent open-market trade on file is a sale of 4,082 ANIP shares on Nov 18, 2026 at $71.16.